DRTS
Alpha Tau Medical Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$15.24
−1.61%0
Insider buys (3m)
10
Insider sells (3m)
-$1.2M
Net value (3m)
+51.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 25, 2026 | Levy Raphi · officer: Chief Financial Officer | M-Exempt | 2,871 | $2.98 |
| Aug 25, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 2,871 | $15 |
| Aug 12, 2026 | Levy Raphi · officer: Chief Financial Officer | M-Exempt | 17,730 | $2.98 |
| Aug 12, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 17,730 | $14 |
| Jul 7, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 2,270 | $14 |
| Jul 7, 2026 | Levy Raphi · officer: Chief Financial Officer | M-Exempt | 2,270 | $2.98 |
| Jul 6, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 17,873 | $13 |
| Jul 6, 2026 | Levy Raphi · officer: Chief Financial Officer | M-Exempt | 17,873 | $2.98 |
| Jul 2, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 2,127 | $13 |
| Jul 2, 2026 | Levy Raphi · officer: Chief Financial Officer | M-Exempt | 2,127 | $2.98 |
| Jul 1, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 20,000 | $12 |
| Jun 26, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 15,778 | $11 |
| Jun 26, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 4,222 | $11 |
| Jun 25, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 2,500 | $10 |
| Jun 25, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 15,000 | $9.47 |
| Jun 4, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 17,500 | $11 |
| Jun 4, 2026 | Levy Raphi · officer: Chief Financial Officer | Sale | 15,000 | $11 |
Institutional positioning
13F filings over the trailing two quarters
New 46Increased 26Reduced 25Sold out 7
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Gem Investment Advisors, LLC | Increased | 1,434,476 | Aug 11, 2026 |
| HighTower Advisors, LLC | Unchanged | 874,994 | Aug 5, 2026 |
| HIGHTOWER ADVISORS, LLC | Increased | 874,994 | May 5, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | New Position | 773,481 | Aug 14, 2026 |
| Aquamarine Financial (Cayman) Ltd | New Position | 721,501 | May 15, 2026 |
| Aquamarine Financial (Cayman) Ltd | Unchanged | 721,501 | Aug 12, 2026 |
| Pier Capital, LLC | New Position | 691,939 | Aug 5, 2026 |
| UBS Group AG | Increased | 642,263 | Aug 13, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 442,267 | Aug 14, 2026 |
| Apella Capital, LLC | Unchanged | 382,284 | Jul 8, 2026 |
| APELLA CAPITAL, LLC | Unchanged | 382,284 | Apr 20, 2026 |
| CITADEL ADVISORS LLC | Increased | 375,459 | Sep 2, 2026 |
| ARK INVESTMENT MANAGEMENT LLC | New Position | 292,134 | May 12, 2026 |
| UBS GROUP AG | Increased | 286,688 | May 5, 2026 |
| ARK Investment Management LLC | Reduced | 277,086 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 25, 2026